NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
The summary for the NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44): This FOA provides additional support to SBIR/STTR Phase II grantees for the validation and commercialization of methods that either replace or reduce the number of animals (referred to as alternative test methods) used in in vivo toxicology screening and testing requirements set forth by US federal government agencies.
Federal Grant Title: | NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches to Reduce Animal Use in Toxicology Testing (U44) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Environment Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-ES-15-016 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.113 |
CFDA Descriptions: | Environmental Health |
Current Application Deadline: | Nov 13, 2017 |
Original Application Deadline: | Nov 13, 2017 |
Posted Date: | Jul 9, 2015 |
Creation Date: | Jul 9, 2015 |
Archive Date: | Dec 14, 2017 |
Total Program Funding: | $3,000,000 |
Maximum Federal Grant Award: | $1,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-15-016.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed...
- • NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advan...
- • Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clini...
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)